ALEC
Price
$3.08
Change
+$0.16 (+5.46%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
296.55M
46 days until earnings call
RGNX
Price
$9.65
Change
+$0.29 (+3.10%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
487.46M
39 days until earnings call
Interact to see
Advertisement

ALEC vs RGNX

Header iconALEC vs RGNX Comparison
Open Charts ALEC vs RGNXBanner chart's image
Alector
Price$3.08
Change+$0.16 (+5.46%)
Volume$21.6K
Capitalization296.55M
REGENXBIO
Price$9.65
Change+$0.29 (+3.10%)
Volume$14.44K
Capitalization487.46M
ALEC vs RGNX Comparison Chart in %
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. RGNX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a StrongBuy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ALEC: $3.09 vs. RGNX: $9.65)
Brand notoriety: ALEC and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 41% vs. RGNX: 31%
Market capitalization -- ALEC: $296.55M vs. RGNX: $487.46M
ALEC [@Biotechnology] is valued at $296.55M. RGNX’s [@Biotechnology] market capitalization is $487.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 5 bearish.
  • RGNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а +1.82% price change this week, while RGNX (@Biotechnology) price change was +8.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 11, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($487M) has a higher market cap than ALEC($297M). ALEC YTD gains are higher at: 55.026 vs. RGNX (24.838). ALEC (-125.18M) and RGNX (-129.93M) have comparable annual earnings (EBITDA) . RGNX has more cash in the bank: 323M vs. ALEC (307M). ALEC has less debt than RGNX: ALEC (39.5M) vs RGNX (77.7M). RGNX has higher revenues than ALEC: RGNX (156M) vs ALEC (81.1M).
ALECRGNXALEC / RGNX
Capitalization297M487M61%
EBITDA-125.18M-129.93M96%
Gain YTD55.02624.838222%
P/E RatioN/AN/A-
Revenue81.1M156M52%
Total Cash307M323M95%
Total Debt39.5M77.7M51%
FUNDAMENTALS RATINGS
ALEC vs RGNX: Fundamental Ratings
ALEC
RGNX
OUTLOOK RATING
1..100
7267
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3650
P/E GROWTH RATING
1..100
9320
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALEC's Valuation (54) in the Biotechnology industry is in the same range as RGNX (70). This means that ALEC’s stock grew similarly to RGNX’s over the last 12 months.

ALEC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that ALEC’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's SMR Rating (98) in the Biotechnology industry is in the same range as ALEC (100). This means that RGNX’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (36) in the Biotechnology industry is in the same range as RGNX (50). This means that ALEC’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's P/E Growth Rating (20) in the Biotechnology industry is significantly better than the same rating for ALEC (93). This means that RGNX’s stock grew significantly faster than ALEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECRGNX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOVX46.82N/A
N/A
Thornburg Global Opportunities R4
VVONX24.44N/A
N/A
Invesco Value Opportunities R5
QLSGX31.91N/A
N/A
Federated Hermes MDT Small Cap Growth R6
SAIEX10.28N/A
N/A
Spirit of America Energy Institutional
UIVCX12.67N/A
N/A
MFS Intrinsic Value C

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with LRMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
-7.28%
LRMR - ALEC
46%
Loosely correlated
-4.71%
RGNX - ALEC
44%
Loosely correlated
-1.89%
TERN - ALEC
44%
Loosely correlated
-5.46%
BEAM - ALEC
44%
Loosely correlated
-2.12%
EYPT - ALEC
41%
Loosely correlated
-6.32%
More